Erectile Dysfunction and NSAID Use

This article comes from Medscape  and references the Journal of Urology. ER can arise from multiple causes, often ocurring simultaneously. The author noted research showing a strong association with NSAID use and erectile dysfunction, even after confounding variables or comorbidities such as age, hypertension, smoking, vascular or heart disease, weight or diabetes were adjusted for.

Regular NSAID Use Linked to Erectile Dysfunction

Laurie Barclay, MD

March 7, 2011 — Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with erectile dysfunction (ED), according to the results of a prospective cohort study reported online February 21 and in the April print issue of the Journal of Urology.

“This study is a great example of how we work to understand the safety and effectiveness of what we recommend for our patients,” said senior author Steven J. Jacobsen, MD, PhD, an epidemiologist and director of research for Kaiser Permanente Southern California in San Diego, in a news release.

“We went into this study thinking we would find the opposite effect: that NSAIDs would have a protective effect because they protect against heart disease, which is also linked to ED. The next step is to dive a bit deeper to understand the underlying physiology of what might be happening with these drugs.”

Beginning in 2002, the California Men’s Health Study enrolled a large, ethnically diverse cohort of male members of the Kaiser Permanente managed care plans who were 45 to 69 years old. A questionnaire evaluated ED, and automated pharmacy data and self-reported use allowed evaluation of NSAID exposure.

NSAID use was present in 47.4% of the 80,966 participants, and moderate or severe ED was reported in 29.3%. NSAID use and ED correlated strongly with age. Regular NSAID use increased from 34.5% in men aged 45 to 49 years to 54.7% in men aged 60 to 69 years, and ED increased from 13% to 42% in these age groups.

Without adjustment for potentially confounding variables, the odds ratio (OR) for the association of NSAIDs and ED was 2.40 (95% confidence interval [CI], 2.27 – 2.53). A positive association persisted after adjustment for age, race/ethnicity, smoking status, diabetes mellitus, hypertension, hyperlipidemia, peripheral vascular disease, coronary artery disease, and body mass index (adjusted OR, 1.38). A positive association also was evident when a stricter definition of NSAID exposure was used.

“There are many proven benefits of non steroidals in preventing heart disease and for other conditions,” Dr. Jacobsen said. “People shouldn’t stop taking them based on this observational study. However, if a man is taking this class of drugs and has ED, it’s worth a discussion with his doctor.”

Limitations of this study include cross-sectional design, potential participation bias, and low original participation rate.

“These data suggest that regular NSAID use is associated with ED even after extensive adjustment for age and potentially confounding factors or comorbidities,” the study authors write.

“While this raises the question of the role of inflammation and COX [cyclooxygenase] pathways in ED etiology, we cannot exclude alternative explanations. However, if this is a direct relationship, the current strategy of using NSAIDs for cardiovascular disease protection as well as other common uses of NSAIDs should be weighed against the potential side effects of ED. Studies are needed to elucidate this association in more detail.”

The California Cancer Research Program and Kaiser Foundation Community Benefit Program supported this study. Some of the study authors have disclosed various financial and/or other relationships with Takada, GlaxoSmithKline, Kaiser Permanente, and/or Merck.

J Urology. Published online February 21, 2011.